FDA approves 1st gene therapy Otarmeni for OTOF hearing loss
NewsBytes | April 25, 2026 4:39 PM CST
Otarmeni trials show 80% improvement
In trials, 80% of children aged 10 months to 16 years showed real improvement in just 24 weeks.
The therapy will be free for eligible US patients.
Inspired by these results, doctors in India are exploring similar research, though access to testing and resources is still a challenge there.
This approval could speed up access to the treatment worldwide and change how genetic deafness is managed.
READ NEXT
-
'Thank You For The Messages, All Good': Lungi Ngidi Issues 1st Message After Head Injury Against PBKS
-
CSK VS GT: Shubman Gill Wins Toss, Opts To Field First In Chennai; No MS Dhoni Yet For Hosts
-
Who Is Dr. Atanu Nath? First Scientist To Receive Breakthrough Award From Northeast India
-
AP SSC Result 2026 Expected Soon At bse.ap.gov.in; Know How To Check Via WhatsApp & SMS
-
Who Was S Ramanujan? Everything About The Man Who Knew Infinity
